A Clinical Hypothesis on Viral Gastroenteritis and Endogenous Incretin Response A curious observation comes up now and then in clinic: a patient with a viral GI illnesstypically marked by nausea, loss of appetite, and sometimes transient weight lossdescribes symptoms eerily similar to what we see in GLP-1 agonist use
If prescribed, your subscription includes: Personalized Treatment Plans Medication and Supplies Shipping to Your Door Purchase Options Compounded semaglutide is a once-weekly injectable GLP-1 medication
Maintaining a healthy immune system and preventing metal and drug poisoning
175 Currently, GSBR-1290 is undergoing a 12-week Phase 2a randomized, double-blind, placebo-controlled clinical trial to assess its effectiveness in treating patients with T2DM and obesity
Updated 11/05/2025 By Starling Krentz, MS and Gabriel Alizaidy, MD, MS The concept of microdosing sounds counterintuitive at first
In addition to lignans, phenolic acids and flavonoids, as well as protocatechiuc and p-coumaril quinic acids were found to be predominant (31)
